BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ONC BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

Post-Mkt 10-08 18:46:44 EDT

350.13

-13.89

-3.82%

盘后350.13

+0.000.00%

17:46 EDT

High355.01	Low340.45	Vol418.69K
Open351.94	D1 Closing364.02	Amplitude4.00%
Mkt Cap39.91B	Tradable Cap28.34B	Total Shares114.00M
T/O145.31M	T/O Rate0.52%	Tradable Shares80.95M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS","latestPrice":350.13,"timestamp":1791489600000,"preClose":364.02,"halted":0,"volume":418687,"hourTrading":{"tag":"盘后","latestPrice":350.13,"preClose":350.13,"latestTime":"17:46 EDT","volume":11714,"amount":4101413.4488000004,"timestamp":1791495964824,"change":0,"changeRate":0,"amplitude":0.009711},"delay":0,"changeRate":-0.038157244107466584,"floatShares":80952700,"shares":113999999,"eps":5.589356,"marketStatus":"Post-Mkt","change":-13.89,"latestTime":"10-08 18:46:44 EDT","open":351.94,"high":355.01,"low":340.445,"amount":145309162.70979,"amplitude":0.040012,"askPrice":352,"askSize":100,"bidPrice":344.91,"bidSize":18,"shortable":3,"etf":0,"ttmEps":5.589356,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791504000000},"marketStatusCode":4,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":364.02,"preHourTrading":{"tag":"盘前","latestPrice":352,"preClose":364.02,"latestTime":"09:27 EDT","volume":11000,"amount":3969316.12,"timestamp":1791466070015,"change":-12.02,"changeRate":-0.03302,"amplitude":0.03302},"postHourTrading":{"tag":"盘后","latestPrice":350.13,"preClose":350.13,"latestTime":"17:46 EDT","volume":11714,"amount":4101413.4488000004,"timestamp":1791495964824,"change":0,"changeRate":0,"amplitude":0.009711},"volumeRatio":1.219033,"impliedVol":0.381,"impliedVolPercentile":0.2669},"requestUrl":"/m/hq/s/ONC","defaultTab":"news","newsList":[{"id":"1124667340","title":"Movement Alert｜BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS Falls 5.1% in Regular Trading, Founding Shareholder's Recent Consecutive Share Reductions Weigh on Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1124667340","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124667340?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:07","pubTimestamp":1791468454,"startTime":"0","endTime":"0","summary":"On October 8, BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS fell 5.1% in regular trading to $344.835 per share, with turnover of $27.7672 million. The primary catalyst behind the move was the consecutive...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BeiGene Falls as Founder Wang Xiaodong Cuts Holdings","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671564251","title":"BeOne Medicines Advances BGB-58067 Tablet Study, Sharpening Early-Stage Investor Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2671564251","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671564251?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:30","pubTimestamp":1790613019,"startTime":"0","endTime":"0","summary":"BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines (ONC) is running a phase 1 study in healthy adults to c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beone-medicines-advances-bgb-58067-tablet-study-sharpening-early-stage-investor-focus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beone-medicines-advances-bgb-58067-tablet-study-sharpening-early-stage-investor-focus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ONC","BK4139","BK4588","MDCO","BK4526","BGB","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120742791","title":"Hong Kong Stocks Open Mixed: Hang Seng Edges Down 0.09%, Tech Index Flat, Memory Chip Plays Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1120742791","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120742791?lang=en_us&edition=fundamental","pubTime":"2026-09-23 09:36","pubTimestamp":1790127394,"startTime":"0","endTime":"0","summary":"US equities delivered a mixed performance on Tuesday, with retreating oil prices lifting overall market sentiment. The Dow opened higher and briefly extended gains before reversing course under...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1303224171.USD","03088","09088","LU1969619763.USD","03067","03037","03419","03423","07552","688235","LU0228659784.USD","09115","ONC","MCHmain","07300","BK1161","KURE","LU0588546209.SGD","LU2328871848.SGD","HSImain","03115","BK1500","82800","02833","LU0828237510.HKD","07200","83115","LU1719994722.HKD","HSI","06160","BK1588","03033","02837","HHImain","BK1583","HSTECH","07500","513600","LU1770034418.SGD","LU0307460666.USD","03032","02800","03417","09067","07226","HTImain","LU1251922891.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666750575","title":"BeOne Medicines Advances BG-85738 Into First-in-Human RAS Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2666750575","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666750575?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:31","pubTimestamp":1789144293,"startTime":"0","endTime":"0","summary":"BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines (ONC) is running a first-in-human Phase 1a/1b study of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beone-medicines-advances-bg-85738-into-first-in-human-ras-cancer-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beone-medicines-advances-bg-85738-into-first-in-human-ras-cancer-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4526","BK4139","MDCO","BK4588","ONC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109390642","title":"UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1109390642","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109390642?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:50","pubTimestamp":1788745830,"startTime":"0","endTime":"0","summary":"UBS has released a research note suggesting that while market expectations for the Chinese biotech sector's first-half results were initially conservative—due to concerns over tighter domestic drug...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","06160","LU2097828805.USD","LU2399975544.HKD","LU0417516738.SGD","LU2778985437.USD","LU1251922891.USD","09926","06990","BK0239","LU0417516902.SGD","LU2328871848.SGD","LU2488822045.USD","00013","LU1961090484.USD","LU0196878994.USD","LU0228659784.USD","LU1969619763.USD","LU2097828557.USD","BK1583","HK0000165453.HKD","IE00BPRC5H50.USD","LU1794554557.SGD","BK1161","LU0348784397.USD","LU0463099449.HKD","LU0348766576.USD","BK1515","03069","IE00B5MMRT66.SGD","LU0348783233.USD","BK4585","BK1589","LU0348825331.USD","LU0455707207.USD","BK4139","LU0502904849.HKD","LU0540923850.HKD","01877","LU0634319403.HKD","LU1188198961.HKD","LU1719994722.HKD","LU2097828474.EUR","ONC","BK1500","LU2097828714.EUR","LU2476274308.USD","LU1770034418.SGD","LU0348767384.USD","LU2097828631.EUR","LU0417516571.SGD","01801","KURE","IE00B543WZ88.USD","LU0307460666.USD","LU2476274720.SGD","BK4588","LU0326950275.SGD","688235","BK4526","BK1588","LU0348735423.USD","LU0561508036.HKD","BK1191","LU0588546209.SGD","LU0244354667.USD","LU2242644610.SGD","09969","LU1303224171.USD","LU0348827113.USD","LU1720050803.USD","BK1574","LU0828237510.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141408111","title":"Brokerage Adds Tencent and Innovent Bio to Buy List While Maintaining Positive Outlook on Tech and Hardware Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1141408111","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141408111?lang=en_us&edition=fundamental","pubTime":"2026-09-04 13:34","pubTimestamp":1788500064,"startTime":"0","endTime":"0","summary":"UOB Kay Hian's latest research report indicates that mainland Chinese equities underwent a consolidation phase during August, with the Hang Seng Index and MSCI China Index retreating 1.2% and 0.4%...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348805143.USD","LU0823038988.USD","LU1171460220.USD","LU0359201612.USD","BK1531","LU0210526637.USD","LU0572944931.SGD","LU0738912210.USD","BK1604","LU2152927971.USD","LU0823039010.USD","LU1224709979.USD","SG9999014880.SGD","LU0819121731.USD","LU1303224171.USD","LU2247934214.USD","LU0683595622.HKD","IE00BZ08YS42.EUR","IE0003895053.USD","LU1051768304.USD","SG9999001226.SGD","LU0737861772.HKD","LU0828237940.HKD","LU1956131251.USD","LU0054237671.USD","SG9999011746.SGD","LU0049853897.USD","LU0414403682.SGD","HK0001040168.HKD","LU0254981946.USD","LU0593848301.USD","LU2293587155.HKD","LU0345769128.USD","IE00B0169N27.USD","LU0488056044.USD","IE00B0JY6N72.USD","SG9999013353.USD","LU0463099449.HKD","BK1609","LU0348788117.USD","LU0823426308.USD","SG9999001093.SGD","LU0106959298.USD","LU0784639295.USD","LU0650527681.SGD","LU0880133367.SGD","LU1226287875.USD","LU2237443465.HKD","IE0032834883.USD","LU2279701549.SGD","LU0235996351.USD","LU1046422090.SGD","LU0128522744.USD","LU0588546209.SGD","LU0831103253.SGD","002008","LU1242518857.USD","LU0878005551.USD","LU1997244956.HKD","LU0633140727.USD","LU2045819591.USD","LU0823413660.USD","IE0008369823.USD","LU0918141705.HKD","HK0000352382.USD","LU0516423174.USD","SG9999001689.USD","LU1102505762.USD","LU0196878994.USD","LU1997245094.SGD","SG9999000475.SGD","LU0173614495.USD","LU0384037296.USD","LU0307460666.USD","LU0228367735.SGD","IE00BQXX3C00.GBP","LU2097828714.EUR","IE0003795394.USD","LU1255011170.USD","LU1880383440.USD","LU1770034418.SGD","LU0261950983.USD","BK1502","LU1960683339.HKD","SG9999001069.SGD","SG9999017495.SGD","LU0502904849.HKD","LU1048588211.SGD","BK0187","LU0314109678.HKD","BK0072","BK0073","LU1781817850.SGD","LU2257852520.SGD","LU1196710351.USD","LU1282651121.HKD","LU0348783233.USD","LU1242518931.SGD","BK1526","SG9999015978.USD","LU1316542783.SGD","LU1880383366.USD","LU2125910500.SGD","SG9999018857.SGD","688235","LU1224444064.USD","LU1868838027.USD","LU0117844026.USD","LU0289960550.SGD","LU0011963245.USD","LU0164865239.USD","LU2328871848.SGD","IE0034224299.USD","LU2148510915.USD","LU0210527791.USD","LU2237443549.SGD","FDNI","BK6044","SG9999015945.SGD","LU0417516902.SGD","LU0070217475.USD","LU0972618739.USD","LU2039709279.SGD","SG9999002828.SGD","BK1615","LU0251144936.SGD","LU1969619763.USD","SG9999001903.USD","LU0143863198.USD","LU1328277881.USD","SGXZ90724238.SGD","LU2153591404.USD","LU0633140560.USD","BKF","IE00BPRC5H50.USD","LU1282651048.USD","LU1974910355.USD","LU0345775950.USD","LU0540923850.HKD","LU0594300419.USD","LU1997245177.USD","LU0164872284.USD","LU0531971595.HKD","LU0106252389.USD","LU2087589342.USD","LU0516423091.SGD","HTCD.SI","LU0251143458.SGD","LU2462611646.USD","LU0878004406.USD","LU0370786039.SGD","LU0516422440.USD","LU0871576103.HKD","LU0039217434.USD","BK0201","CXSE","IE00B031J352.USD","LU1023057109.AUD","LU0499858602.USD","SG9999015986.USD","LU2097828474.EUR","LU0244354667.USD","LU0572940350.SGD","SG9999018865.SGD","BK1591","BK0152","LU0214875030.USD","SG9999001051.SGD","LU0203345920.USD","EMCS","LU0865486749.SGD","LU0642271901.SGD","LU1804176565.USD","LU1226287792.SGD","LU1211504680.USD","LU0348783662.USD","SG9999007991.SGD","LU0261947096.USD","LU0029875118.USD","LU0287142896.SGD","BK0132","LU2289578879.USD","LU1102505929.USD","LU0348827113.USD","LU1951186391.HKD","LU0823397103.USD","LU2506952253.HKD","LU0326948709.USD","LU0456842615.SGD","LU0577902538.SGD","LU0541501648.USD","LU0873338254.USD","BK1500","LU1226288097.SGD","LU0348814723.USD","LU0868486357.SGD","HK0000306685.HKD","LU0149721374.USD","LU0067412154.USD","LU2237443382.USD","LU1044874839.SGD","LU0651946864.USD","LU1629966141.USD","IE00B067MR52.USD","SGXZ99366536.SGD","LU0890818403.SGD","LU0441854154.USD","BK1586","LU0203347892.USD","BK0155","LU3063872942.SGD","LU0469268626.HKD","BK1610","IE00BZ08YR35.GBP","HK0000151867.HKD","LU0791591158.USD","LU1504937902.USD","LU1328615791.USD","SG9999000459.SGD","LU1282649067.USD","FFEM","LU1064131003.USD","LU1008478684.HKD","BK0188","HK0000914686.HKD","LU1115378108.SGD","JADE","LU1655091616.SGD","LU1734074674.USD","LU0348816934.USD","LU2362541273.HKD","LU0589944569.HKD","LU1196710864.SGD","LU1282648689.USD","SG9999001846.SGD","SG9999004220.SGD","IE00BQXX3D17.EUR","LU2251237488.HKD","LU0708995583.HKD","LU2051468812.USD","IE00BF5LJ272.USD","SG9999014906.USD","LU0049112450.USD","LU0417516571.SGD","LU0543330566.HKD","LU0345776255.USD","LU1733274390.USD","LU0327786744.USD","GAMR","09961","LU1655091459.SGD","EMC","LU0821914370.USD","IE00B29SXG58.USD","LU2251237306.USD","ONC","LU0672654166.SGD","LU0605514214.HKD","SG9999014914.USD","LU0431992006.USD","LU0882747503.HKD","LU1718418525.SGD","HK0000288784.HKD","LU0264606111.USD","LU0608807946.USD","LU1146622755.USD","LU2317271919.USD","SG9999002463.SGD","SGXZ49509284.SGD","LU0345769631.USD","SG9999000327.SGD","LU0577902371.SGD","LU2265009873.SGD","LU0315179316.USD","LU0320764243.SGD","LU0048575426.USD","LU1039395188.USD","LU0509642566.USD","BK0070","HK0000165453.HKD","LU2097828557.USD","LU0396098781.USD","LU0516422952.EUR","TCEHY","LU0320764755.SGD","BK1164","LU1868837722.USD","JEMA","LU0043850808.USD","LU2177674079.SGD","LU0737861699.HKD","LU0819123356.HKD","LU0127658192.USD","SG9999006514.SGD","SG9999003461.SGD","LU1515016050.SGD","LU0274383776.USD","LU2237443978.SGD","LU1439102457.SGD","IE0032431581.USD","LU0561508036.HKD","LU1733274473.HKD","BK1161","LU0359201885.HKD","LU0192582467.USD","LU1691799644.USD","SGXZ51526630.SGD","LU0543330483.HKD","KURE","LU1814569148.SGD","LU1568876335.HKD","LU2294711473.HKD","LU0054450605.USD","U10.SI","LU0708995153.HKD","LU2097828631.EUR","LU0823397285.USD","LU0326950275.SGD","LU0188438112.USD","LU1366334651.USD","LU0823426480.USD","LU0072913022.USD","LU0862451837.USD","LU0918141887.USD","LU1251922891.USD","LU1993786604.SGD","LU1152091754.HKD","LU1720050803.USD","LU0348825331.USD","BIDD","SGXZ31699556.SGD","TCOM","LU0862451753.SGD","LU1770036033.HKD","LU1044875133.USD","LU1808992512.USD","LU2498475776.HKD","LU1642822792.SGD","LU0163747925.USD","BK1583","LU0572939691.SGD","LU0499858438.USD","LU0823437842.USD","SGXZ81514606.USD","LU0449509016.USD","SG9999002414.USD","IE0008368411.USD","IE0003851619.USD","LU0259732245.USD","BK0064","LU1868837565.USD","LU2488822045.USD","LU0577902454.USD","LU0164880469.USD","LU1820825898.SGD","LU0700851271.USD","LU0169518387.USD","IE0031814852.USD","LU1883866441.USD","AAXJ","LU1188198961.HKD","LU1439103000.SGD","LU1044876610.USD","LU1105468828.SGD","LU3227948356.SGD","LU2023250504.SGD","BK1516","LU0455707207.USD","LU1481107354.HKD","LU2931357623.SGD","LU0117841782.USD","GB00BDT5M118.USD","IE00B8HQ1Z84.USD","LU0823040885.USD","LU2348773727.SGD","LU0594300179.USD","IE00B031HW06.USD","LU1048484197.HKD","LU1813983027.USD","LU2008162690.USD","002371","LU0501845795.SGD","LU0588545730.USD","IE00B8L5B284.USD","BK1095","LU0080751232.USD","LU1226287529.USD","BK0077","LU1807302812.USD","BK0028","SG9999006597.SGD","LU1917777945.USD","ESPO","LU0607220059.USD","LU2495084118.USD","LU0106259558.USD","LU0348735423.USD","LU0211331839.USD","LU0181495838.USD","LU1366334578.USD","LU0269904917.USD","LU0228659784.USD","LU2089985449.USD","EEMX","LU0140636845.USD","LU1282649141.HKD","LU2125910849.SGD","LU0231483743.USD","KWEB","LU2424517915.HKD","LU0648948544.HKD","LU0823041008.USD","LU2226246903.HKD","LU0531970944.HKD","LU0588545490.SGD","LU0211977185.USD","SG9999002562.SGD","LU0165289439.USD","BK0196","BK1588","LU1785774172.SGD","LU0328353924.USD","LU0096374516.USD","LU1725190679.HKD","LU2106854487.HKD","LU2242644610.SGD","HK0000320223.HKD","LU0048580855.USD","LU0149534421.HKD","LU2778985437.USD","LU0541502299.USD","06160","LU1235295612.USD","LU0048388663.USD","LU1769817096.USD","LU1226288253.USD","LU0048597586.USD","LU0229945570.USD","LU0516422366.SGD","LU1831875114.USD","BK1618","XSOE","BK0061","LU1064130708.USD","ODDS","LU1981816686.USD","LU2449936058.SGD","IE00B031HY20.USD","LU2476274308.USD","IE00B97KM107.HKD","LU1048596156.SGD","HK0000352291.HKD","HK0000320264.USD","LU0640798160.USD","LU0823413587.USD","LU0348723411.USD","IE00BQXX3F31.USD","EVS.SI","BK0251","IE00BGV7N243.SGD","LU2279858448.HKD","IE0008368742.USD","LU2362541513.USD","LU0608807433.USD","LU0828238088.HKD","LU0856984785.SGD","LU0651947912.USD","LU0143863784.USD","LU1226288170.HKD","LU0985320562.USD","BK1521","LU1568876251.USD","LU0359202008.SGD","BK0224","SG9999002406.SGD","LU0797268264.HKD","LU0611395673.USD","LU0348784397.USD","BK1587","BK1517","SG9999014898.SGD","LU0588545904.SGD","LU1282649810.SGD","LU0175139822.USD","LU0052750758.USD","LU1196710195.USD","LU1688375341.USD","BK1589","LU0675040207.SGD","LU0315178854.USD","BK6516","LU2476274720.SGD","LU2237443622.USD","IE00B0169L03.USD","LU1794554557.SGD","LU0293314216.USD","LU0329678170.USD","HK0000288743.USD","SG9999015952.SGD","LU0061477393.USD","LU2362540622.SGD","IE00B543WZ88.USD","LU0886674414.USD","BK1608","LU1580142542.USD","LU1675838814.USD","LU0261950470.USD","SG9999014674.SGD","TCHI","LU0449515922.USD","IE00B5MMRT66.SGD","IE00B3M56506.USD","LU0898667661.SGD","LU1323998911.USD","LU0456846285.SGD","LU2399975544.HKD","LU0828237510.HKD","BK0125","LU2133065610.SGD","LU1719994722.HKD","SOCL","LU0634319403.HKD","LU1051769294.HKD","HK0000306701.USD","LU0210533765.USD","LU0084288322.USD","LU0456827905.SGD","LU0329678337.USD","IE0009570106.USD","LU0051755006.USD","LU0107464264.USD","HK0001040143.USD","LU0786609619.USD","LDEM","LU0072462343.USD","LU0577902611.USD","300014","LU2097828805.USD","LU0029874905.USD","LU0577902298.EUR","LU1810669033.SGD","IE00BZ08YT58.USD","LU0047713382.USD","HK0000914660.USD","LU0128522157.USD","LU1152091168.USD","SG9999000418.SGD","LU0320764599.SGD","LU0417516738.SGD","LU1961090484.USD","01801","LU0979878070.USD","LU0132412106.USD","SGXZ81163826.USD","00700","LU2237443895.HKD","LU1769817179.HKD","IE0001KFT4U8.USD","LU0791590937.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664568448","title":"Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568448?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:49","pubTimestamp":1788263354,"startTime":"0","endTime":"0","summary":"FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreementsSept 1 (Reuters)-U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","LU2023250843.SGD","IE00B7KXQ091.USD","LU1236620750.USD","LU0708994859.HKD","LU2461242641.AUD","LU0306807586.USD","LU1244550221.USD","LU0198837287.USD","LU0426417589.USD","LU1670627923.USD","LU0079474960.USD","LU2133065610.SGD","LU0672654240.SGD","LU2213496289.HKD","IE000WAW04H5.SGD","IE00B19Z3581.USD","SG9999001176.SGD","LU2430703095.HKD","LU1670710588.SGD","LU0256863902.USD","LU1670710661.SGD","LU1127390331.HKD","LU2023251221.USD","PJP","LU1720051017.SGD","LU0787776722.HKD","LU1066051498.USD","LU0792757196.USD","LU2106854487.HKD","LU1868836914.USD","LU1116320901.HKD","LU0310799852.SGD","LU1121112475.USD","LU0158827948.USD","LU2129689431.USD","THNR","LU0320765992.SGD","LU2552382132.HKD","LLYZ","BMY","LU2168564495.EUR","LU2462591350.SGD","IBB","IE00B1XK9C88.USD","04332","IE000M9KFDE8.USD","LU0965509010.AUD","LU0265550946.USD","LU0965509101.SGD","LU1261432733.SGD","LU0094547139.USD","LU0029864427.USD","LU0912757837.SGD","SG9999015341.SGD","LU2237443978.SGD","SG9999015986.USD","BK7501","BK4581","LU0069063385.USD","LU2505996681.GBP","LU1244550494.USD","LU1989772840.SGD","SG9999011175.SGD","IE00B19Z3B42.SGD","GLAM","BK7067","LU1023059063.AUD","ABBV","LU0889565916.HKD","LU2111349929.HKD","LLYX","LU0061475181.USD","LU1037948897.HKD","LU0238689110.USD","NVOX","LU0689626769.HKD","LU1883839398.USD","LU2129689605.HKD","LU0306806265.USD","LU2746668461.USD","LU0965508806.USD","LU0097036916.USD","LU0395794307.EUR","LU1221951046.USD","LU1280957306.USD","LU1674673428.USD","LU0006306889.USD","LU1929549753.HKD","LLY","LU1066053197.SGD","NVO","LU0154236417.USD","LU2592432038.USD","LU0980610538.SGD","SG9999015978.USD","LU0882574055.USD","LU1032466523.USD","LU0353189680.USD","LU0234570918.USD","LU2433249047.HKD","LU2211815571.USD","GDOC","LU2028103732.USD","LU2129689514.USD","IE00BN29S564.USD","LU1201861249.SGD","LU1629891620.HKD","BK4585","LU2324357040.USD","LU2491049909.HKD","SG9999001440.SGD","LU1732800096.USD","LU0211328371.USD","LU1699723380.USD","LU1670711123.USD","BK4533","LU2417539215.USD","LU1061106388.HKD","LU0070302665.USD","IE00BKDWB100.SGD","LU1894683264.USD","LU1496350171.SGD","LU2362541513.USD","LU1914381329.SGD","LU0158827781.USD","SG9999014559.SGD","BK4139","LU1934455277.USD","LU0345769128.USD","LU1989771016.USD","MHIP","GSK","BK4534","LU2125154778.USD","GSKH","LU1839511570.USD","LU0072461881.USD","LU0321505868.SGD","LU0385154629.USD","IE0004445015.USD","LU2237438978.USD","LU2264538146.SGD","LU1988902786.USD","BK4516","LU0823416689.USD","BK7508","LU2237443895.HKD","JNJ","LU0640476718.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","NVOH","LU0096364046.USD","LU0868494617.USD","LU0162691827.USD","LU1720051108.HKD","ELIL","LU1228905037.USD","LU0985320562.USD","NVS","LU0345770993.USD","LU1267930730.SGD","LU1037948541.HKD","CANC","IE0001KFT4U8.USD","IE00BLSP4239.USD","LU0471298777.SGD","LU1232071149.USD","TRUH","LU0098860793.USD","MEDI","IE00BFTCPJ56.SGD","SG9999003800.SGD","LU0432979614.USD","VHT","IE00BFSS7M15.SGD","LU1941712348.USD","IHE","LU2236285917.USD","LU1585245621.USD","LU0861579265.USD","LU0174119429.USD","LU0122379950.USD","LU0267386448.USD","PAWZ","LU1035773651.USD","LU1804176565.USD","IE000MB6IJN5.SGD","LU1032955483.USD","LU2168564222.USD","LU0057025933.USD","IE00BSNM7G36.USD","IE00BDGV0183.EUR","LU1267930573.SGD","LU2471134952.CNY","IE000F7OJYX1.SGD","LU2602419157.SGD","IE00BKPKM429.USD","LU0203201768.USD","MRK","LU0456855351.SGD","TMED","LU2750360641.GBP","SGXZ99366536.SGD","LU1983299246.USD","LU0320765059.SGD","IE000SO60NU8.SGD","IE00BFXG1179.USD","LU0795875169.SGD","PFE","SG9999014542.SGD","SGXZ80539844.SGD","BK7511","LU0225284248.USD","SG9999018865.SGD","ILDR","LU0211327993.USD","LU0477156953.USD","BK4583","LU2403377893.USD","LU2462157665.USD","IE00BJJMRY28.SGD","LU0868494708.USD","LU1069347547.HKD","LU0708995401.HKD","SG9999014906.USD","LU0943347566.SGD","LU1935042991.SGD","LU2456880835.USD","LU2112291526.USD","LU1506573853.SGD","LU1941712264.USD","IE00B4JS1V06.HKD","LU1868837136.USD","LU0472753341.HKD","LU2089283258.USD","LU0256863811.USD","LU2552382058.USD","LU0511384066.AUD","OZEM","LU2168563687.JPY","BMED","IYH","LU0320765489.SGD","LU2471134796.USD","IE00BVYPNV92.GBP","LU2362540622.SGD","LU2362541273.HKD","LU0820561818.USD","LU0070217475.USD","LU1674673691.USD","LU1116320737.USD","BK4007","LU2471134523.USD","PPH","IE00BGHQF631.EUR","LU2746668974.SGD","LU2125909247.SGD","LU1917777945.USD","LU1989772923.USD","LU2430703251.USD","LU2756315664.SGD","IE00BN8TJ469.HKD","LU0965509283.SGD","IE00BK4W5M84.HKD","LU2089284900.SGD","LU2491050154.USD","LU0545562505.USD","LU0320765646.SGD","IE00BBT3K403.USD","LU1548497426.USD","LU0648001328.SGD","IE00BJLML261.HKD","LU1145028129.USD","LU0265550359.USD","LU1979441026.SGD","LU2087621335.USD","IE00B775H168.HKD","LU1814569148.SGD","IE00BWXC8680.SGD","LU2271345857.HKD","SGXZ57979304.SGD","LU2491050071.SGD","ELIS","LU0266013472.USD","CSL.AU","IE000BZT7R73.USD","LU0661504455.SGD","LU0106261372.USD","LU2125909593.SGD","FHLC","LU1066051225.USD","LU2242652126.USD","LU1323610961.USD","GB00BDT5M118.USD","LU2357305700.SGD","SGXZ51526630.SGD","AZNH","IE00BJJMRX11.SGD","BK4504","BK4550","LU1069344957.HKD","LU1868837300.USD","SG9999017495.SGD","LU1732799900.SGD","IBBQ","LU1057294990.SGD","IE0002270589.USD","LU1066051811.HKD","LU0203345920.USD","LU0345770308.USD","LU0354030438.USD","SG9999001176.USD","LU0124676726.USD","LU1236620834.HKD","LU2237443465.HKD","LLII","LU0823434740.USD","LU0316494557.USD","IE0009355771.USD","LU2023250504.SGD","LU2125154935.USD","LU2265009873.SGD","IE00BLSP4452.SGD","LU0208291251.USD","LU0471298694.HKD","SG9999014575.USD","LU1267930490.SGD","LU2360032135.SGD","LU0289739699.SGD","IXJ","LU1778281490.HKD","LU2237443622.USD","IE00BJT1NW94.SGD","LU0354030511.USD","BK4532","LU0210528500.USD","LU0289739343.SGD","LU2361045086.USD","SG9999014567.USD","LU1670711040.USD","AZN","LU1868836757.USD","LU1043141123.HKD","LU1551013342.USD","LU2430703178.SGD","LU0795875086.SGD","LU0323591593.USD","LU2552382215.SGD","PBE","RXL","LU0203202063.USD","LU0726765562.USD","LU0133085943.USD","LU0964807845.USD","LU0738911758.USD","IE0002141913.USD","LU1228905540.USD","BBIO","LU0058720904.USD","LU1691799644.USD","LU1221951129.SGD","LU0994945656.USD","SG9999014880.SGD","BK4559","SG9999015952.SGD","LU1064131342.USD","BK4592","SG9999002224.SGD","IE00B42XCP33.USD","LU1670628061.USD","LU0942090050.USD","LU0820562030.AUD","LU0114720955.EUR","IE00BVYPNW00.USD","AGNG","IE00B1BXHZ80.USD","LU1496350502.SGD","IE0005OL40V9.USD","LU1093756168.USD","SGXZ31699556.SGD","IE00B7SZLL34.SGD","LU1974910355.USD","NVOC","LU1267930813.SGD","SG9999013999.USD","LU2168564149.EUR","TBXU","IE0004445239.USD","LU1003077747.HKD","LU0889566641.SGD","LU1868836591.USD","LU0553294199.USD","LU0109394709.USD","IE00BZ1G4Q59.USD","LU2357627491.SGD","BK4568","SG9999014898.SGD","LU2168564065.EUR","SG9999002232.USD","LU0130102774.USD","IE00B4R5TH58.HKD","LU0203347892.USD","LU1162221912.USD","WDNA","LU0310800379.SGD","LU1043141396.HKD","LU1571399168.USD","LU1934455194.USD","LU2750360997.AUD","AMGN","LU2237443382.USD","BK4578","LU1244550577.SGD","LU0321505439.SGD","LU0859254822.USD","LU2347655073.USD","LU0289961442.SGD","LU2063271972.USD","LU2242646821.SGD","LU0545039389.USD","LU0689472784.USD","LU2087625088.SGD","LU1366192091.USD","BK4588","IE00B3T34201.USD","LU1718418525.SGD","SG9999018857.SGD","LU0237698245.USD","LU0985481810.HKD","SG9999014914.USD","JDOC","BK4566","IE00B2B36J28.USD","LU1059921491.USD","LU2468319806.SGD","REGN","LU0820561909.HKD","LU1551013425.SGD","LU1291159041.SGD","LU1923622614.USD","LU2361044865.SGD","LU1829250122.USD","LU2237443549.SGD","BK0239","HRTS","LU2089984988.USD","GILD","LU0053666078.USD","LU0211331839.USD","LU0170899867.USD","LU1035775433.USD","LU2505996509.AUD","XLV","LU0417517546.SGD","LU0882574139.USD","IE0034235303.USD","688235","LU0128525929.USD","LU2596442595.SGD","LU1623119135.USD","BBH","LU1074936037.SGD","LU1093756325.SGD","LU1196500208.SGD","LU0683600562.USD","LU0786609619.USD","LU0109391861.USD","LU0353189763.USD","LU2487616109.SGD","FTXH","IE0000B7K699.USD","LU2360106947.USD","ONC","LU0210536198.USD","LU0130517989.USD","LU0225283273.USD","LU0426412945.USD","06160","SG9999015358.SGD","LU0466842654.USD","LU0345769631.USD","IE00BFSS8Q28.SGD","LU2347655156.SGD","MEDX","LU2023250330.USD","LU0823434583.USD","BK4505","LU0949170772.SGD","LU2756315318.SGD","LU1934455863.HKD","LU2896262040.SGD","CURE","LU2361044949.HKD","LU2108987350.USD","LU2471134879.HKD","SGXZ81514606.USD","IE00B3PB1722.GBP","BIB","BK4599","IE00BKVL7J92.USD","SG9999015945.SGD","GSK.UK","LU1712237335.SGD","LU1430594728.SGD","LU1894683348.USD","IE00BK4W5L77.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664309048","title":"White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2664309048","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664309048?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:57","pubTimestamp":1788256679,"startTime":"0","endTime":"0","summary":"The White House made nine new agreements with pharmaceutical manufacturers to bring prescription drug prices for Americans down to the lowest prices paid by other developed nations, it said on Monday.The nine manufacturers include Teva Pharmaceuticals , BridgeBio , Alcon , BeOne Medicines , Astellas Pharma, CSL, Kyowa Kirin, Sun Pharma, and UCB, the White House said.The drugs include treatments for hemophilia, Parkinson's disease, macular degeneration, glaucoma, liver disease, skin conditions, and various forms of cancers, the White House said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BBIO","BK4198","BK4585","BK4526","TEVA","BK4596","ALC.AU","BK4559","BK4557","LU1983299246.USD","LU2265009873.SGD","ONCO","BK7094","BK4505","LU1804176565.USD","BK4534","BK4588","BK4566","BK4584","ONC","ALC","LU2324357040.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106179811","title":"BeiGene Expands Access to Innovative Cancer Therapy Through New U.S. Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=1106179811","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106179811?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:30","pubTimestamp":1788219019,"startTime":"0","endTime":"0","summary":"BeiGene (06160) has announced a voluntary agreement with the U.S. government, designed to broaden patient access to its innovative cancer treatments under the Medicaid program.The deal is part of a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","LU2328871848.SGD","KURE","LU0828237510.HKD","688235","BK1588","LU1719994722.HKD","LU1251922891.USD","BK4585","LU0307460666.USD","BK4139","BK4526","BK0239","ONC","BK1583","LU0228659784.USD","BK1161","LU1770034418.SGD","LU0588546209.SGD","06160","BK4588","LU1303224171.USD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664888906","title":"BeOne Medicines Reaches US Accord on Drug Access, Domestic Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664888906","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664888906?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:56","pubTimestamp":1788206200,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) voluntarily agreed with the US government to expand patient access to its cancer medicines and increase US manufacturing operations, the company said Monday.The company said it w","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4526","BK4139","BK4588","MDCO","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000775","title":"BeOne Medicines to expand access to cancer medicines under pact with U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000775","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000775?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:05","pubTimestamp":1788203107,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) announced a voluntary agreement with the U.S. Government to “expand access to innovative cancer medicines for American patien...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beone-medicines-to-expand-access-to-cancer-medicines-under-pact-with-u-s-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beone-medicines-to-expand-access-to-cancer-medicines-under-pact-with-u-s-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4139","ONC","BK4526","MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663074010","title":"BeOne Medicines Reports Positive Phase 3 Survival Data for Ziihera Regimens","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074010","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663074010?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:36","pubTimestamp":1788172616,"startTime":"0","endTime":"0","summary":"BeOne Medicines  said Monday that Ziihera plus chemotherapy showed statistically significant and clinically meaningful overall survival benefit in a phase 3 trial for HER2-positive gastroesophageal adenocarcinoma.The trial met the remaining primary endpoint, with the combination regimen improving overall survival compared with trastuzumab plus chemotherapy, the company said.The analysis also showed longer-term results for Ziihera with Tevimbra and chemotherapy, including an improved overall survival hazard ratio and durable outcomes, and a manageable safety profile, it said.Shares of BeOne Medicines were 1.8% lower in Monday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ONC","BK4526","MDCO","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141434847","title":"Beone Medicines' First-Half Profit Surges 386% as Core Drug Drives Revenue Past $3.2 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1141434847","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141434847?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:44","pubTimestamp":1787741086,"startTime":"0","endTime":"0","summary":"Beone Medicines has delivered a stellar first-half performance for fiscal 2026, with profitability climbing sharply year-on-year and validating the effectiveness of its commercial strategy.According...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","BK1500","BK4588","BK4526","LU0828237510.HKD","LU0228659784.USD","BK1588","LU1969619763.USD","LU2328871848.SGD","BK0239","BK4139","LU1251922891.USD","BK1161","KURE","LU1770034418.SGD","ONC","688235","BK1583","LU1719994722.HKD","BK4585","LU0588546209.SGD","LU0307460666.USD","LU1303224171.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107537379","title":"BEONE MEDICINES Reports Strong First-Half Profit Surge of 385.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107537379","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107537379?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:16","pubTimestamp":1787739404,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES (06160) has unveiled its interim results for the six months ended June 30, 2026, posting a net profit of $464 million, a substantial year-on-year increase of 385.8%.The company's...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0828237510.HKD","ONC","LU2328871848.SGD","BK4139","BK1583","LU0307460666.USD","BK4588","LU1303224171.USD","LU1969619763.USD","KURE","BK1588","BK4585","LU1719994722.HKD","LU1251922891.USD","06160","688235","BK4526","BK0239","LU1770034418.SGD","BK1500","LU0228659784.USD","BK1161","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662175580","title":"BeOne Medicines' Tacabrutideg Presents 'Sizable Opportunity' in CSU, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2662175580","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662175580?lang=en_us&edition=fundamental","pubTime":"2026-08-25 23:12","pubTimestamp":1787670744,"startTime":"0","endTime":"0","summary":"BeOne Medicines'  BTK degrader tacabrutideg presents a \"sizable opportunity\" in chronic spontaneous urticaria or CSU, RBC Capital Markets said in a Tuesday note.CSU is an inflammatory skin condition that can be a major market with peak sales estimates of about $3 billion, the brokerage said. BTK degraders have the potential to top BTK inhibitors in CSU, likely exceeding inhibitors in terms of potency and effect durability, RBC noted.Nurix Therapeutics  has reported that its BTK degrader bexobrutideg demonstrated greater potency in CSU compared with Novartis'  BTK inhibitor remibrutinib, and RBC sees tacabrutideg's overall efficacy profile as \"broadly comparable\" with bexobrutideg, according to the note.BeOne Medicines is planning to advance tacabrutideg to phase 2 studies in CSU, RBC noted.RBC has an outperform rating and $450 price target on BeOne Medicines.Price: 376.42, Change: +4.44, Percent Change: +1.19","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0070302665.USD","BK4588","PPH","LU0211331839.USD","BK4007","NVS","ONC","BK4139","IE00BFTCPJ56.SGD","BK4585","BK4532","BK4578","MEDX","IE00B4R5TH58.HKD","MDCO","IE00BJT1NW94.SGD","LU0320765489.SGD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","NRIX","IE0002141913.USD","LU0208291251.USD","BK4526","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662530687","title":"BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA","url":"https://stock-news.laohu8.com/highlight/detail?id=2662530687","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662530687?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:45","pubTimestamp":1787669120,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) announced that the U.S. FDA has approved the supplemental Biologics License Application for TEVIMBRA in combination with ZIIH...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beone-announces-fda-approval-for-tevimbra-based-reginmen-for-her2-gea-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beone-announces-fda-approval-for-tevimbra-based-reginmen-for-her2-gea-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","MRNY","BK4585","IYH","PSCH","LABU","BK4588","ONC","BK4139","BBP","XLVX","IEIH","RSPH","TBXU","MEDI","GDOC","FRTY","NVIB","IBB","TECB","PINK","LFSC","MRNX","BMED","GNMX","SYNB","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662273574","title":"Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662273574","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662273574?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:40","pubTimestamp":1787654408,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on GE Healthcare Technologies Inc (GEHC), Biogen (BIIB)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-biogen-biib-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-biogen-biib-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","PBE","LU0689626769.HKD","LABU","LU0889565916.HKD","NATO","XAR","BK4139","BK4581","LU1066051498.USD","LU0943347566.SGD","LU2168564065.EUR","LU2543165471.USD","LU2756315664.SGD","LU1366192091.USD","EXI","TRUI","LU0354030438.USD","BK4543","PPA","LU1280957306.USD","DFEN","MDCO","BK4187","LU0689472784.USD","MISL","LU1551013425.SGD","GE","GEHC","IE00B894F039.SGD","IE00B19Z9P08.USD","LU0868494617.USD","XBI","UXI","LU2264538146.SGD","BK4588","LU0354030511.USD","ITA","BK4526","LU0109394709.USD","LU2168564222.USD","LU1988902786.USD","LU0077335932.USD","ONC","BIIB","BMED","LU1551013342.USD","LGHT","LU0353189763.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660980444","title":"BeOne Medicines (ONC), What Is Behind The Fresh Attention Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660980444","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660980444?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:24","pubTimestamp":1787127890,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) stock is in focus after the company reported significantly improved second quarter 2026 earnings and raised its full year revenue and GAAP operating income guidance earlier this month.\nSee our latest analysis for BeOne Medicines.\nFollowing the earnings beat and raised 2026 guidance, BeOne Medicines stock has picked up momentum, with an 18.31% 1 month share price return and a 19.57% 3 month share price return. That sits alongside an 18.12% 1 year total shareholder return...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/beone-medicines-onc-what-is-behind-the-fresh-attention-now","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/beone-medicines-onc-what-is-behind-the-fresh-attention-now","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4139","BK4585","ONC","BK4526","MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660469996","title":"BeOne Medicines, Foundations Renew Deal to Deliver Cancer Medicine to Poor Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2660469996","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660469996?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:27","pubTimestamp":1787048858,"startTime":"0","endTime":"0","summary":"BeOne Medicines , the BeOne Care Foundation, and The Max Foundation have renewed their partnership through 2028 to expand access to Brukinsa for the treatment of chronic lymphocytic leukemia in low- and middle-income countries, the organizations said Tuesday.The program is planned to support around 1,000 patients, they said.The program has given access to the drug to 300 patients in Armenia, Ethiopia, and Nepal, they said.The partnership combines Max Foundation's expertise in overseeing oncology access programs with donated Brukinsa and includes a $1 million grant from the BeOne Care Foundation, the organizations said.Shares of the company were up 1.2% in recent premarket trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDCO","BK4588","BK4139","BK4585","ONC","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123461158","title":"Beone Medicines Rises 1.34% With H1 Revenue Reaching 22.2 Billion Yuan as Global Expansion Accelerates","url":"https://stock-news.laohu8.com/highlight/detail?id=1123461158","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123461158?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:11","pubTimestamp":1787047890,"startTime":"0","endTime":"0","summary":"Beone Medicines closed at 293.78 yuan today, up 1.34%, with a trading volume of 1.736 billion yuan, a turnover rate of 5.147%, and a volume ratio of 0.71. The company's total market capitalization...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","BK4139","LU1719994722.HKD","BK1500","LU1251922891.USD","688235","LU1969619763.USD","LU2328871848.SGD","KURE","BK4526","LU0307460666.USD","LU0588546209.SGD","BK0239","ONC","BK4588","LU1303224171.USD","BK1588","LU0228659784.USD","BK1583","LU0828237510.HKD","LU1770034418.SGD","BK1161","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":-0.0052},{"period":"1month","weight":0.0161},{"period":"3month","weight":0.2021},{"period":"6month","weight":0.1755},{"period":"1year","weight":0.0656},{"period":"ytd","weight":0.1982}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0091},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.1439},{"period":"1year","weight":0.1616},{"period":"ytd","weight":0.1398}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BeOne Medicines AG, formerly BeiGene, Ltd., is a global oncology company engaged in discovering and developing treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, the Company is engaged in the development of its diverse pipeline of novel therapeutics. Its products include Brukinsa, Tevimbra and Pamiparib. Brukinsa is an orally available, small-molecule inhibitor of Bruton’s tyrosine kinase (BTK). Tevimbra is a humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is designed to minimize binding to Fc-gamma (Fcy) receptors on macrophages, helping the body’s immune cells detect and fight tumors. The Company’s product pipeline in development includes Sonrotoclax, Tarlatamab, Zanidatamab, Blinatumomab, BGB-26808, BGB-R046, BG-68501, BG-C9074, BGB-43395, Xaluritamig, and others.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.083709},{"month":2,"riseRate":0.6,"avgChangeRate":0.027535},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.02929},{"month":4,"riseRate":0.363636,"avgChangeRate":0.018832},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.019621},{"month":6,"riseRate":0.454545,"avgChangeRate":0.010403},{"month":7,"riseRate":0.818182,"avgChangeRate":0.143728},{"month":8,"riseRate":0.636364,"avgChangeRate":0.043626},{"month":9,"riseRate":0.636364,"avgChangeRate":0.064823},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.004583},{"month":11,"riseRate":0.6,"avgChangeRate":0.063715},{"month":12,"riseRate":0.3,"avgChangeRate":-0.043663}],"exchange":"NASDAQ","name":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS","nameEN":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS","securityTypeName":"DR","adrRate":"1:13"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS,ONC,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票老虎,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票老虎国际,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS行情,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票行情,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股价,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股市,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票价格,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票交易,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票购买,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction